Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...

Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Belvidere-based Edible Garden is bringing something new to the table. After a successful pilot production, the hydroponic ...

The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...